Advances in immunotherapy for metastatic renal cancer

曹达龙; 叶定伟

doi:10.19401/j.cnki.1007-3639.2017.10.011

您当前的位置：

首页 >

文章列表页 >

Advances in immunotherapy for metastatic renal cancer

更新时间：2025-12-31

- Advances in immunotherapy for metastatic renal cancer
- China Oncology Vol. 27, Issue 10, Pages: 829-832(2017)
- 作者机构：
  
  复旦大学附属肿瘤医院泌尿外科，复旦大学上海医学院肿瘤学系,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2017.10.011
  CLC：
- Published Online：05 December 2017，
  
  Published：05 December 2017
- 稿件说明：
移动端阅览
曹达龙,叶定伟 . 转移性肾癌中免疫治疗的研究进展[J]. 中国癌症杂志, 2017, 27(10): 829-832.

曹达龙, 叶定伟. Advances in immunotherapy for metastatic renal cancer[J]. China Oncology, 2017, 27(10): 829-832.
曹达龙,叶定伟 . 转移性肾癌中免疫治疗的研究进展[J]. 中国癌症杂志, 2017, 27(10): 829-832. DOI： 10.19401/j.cnki.1007-3639.2017.10.011.

曹达龙, 叶定伟. Advances in immunotherapy for metastatic renal cancer[J]. China Oncology, 2017, 27(10): 829-832. DOI： 10.19401/j.cnki.1007-3639.2017.10.011.

摘要

肾癌是男性泌尿生殖系统中常见的恶性肿瘤。然而，约25%的肾癌在确诊时已是晚期，另有1/3的局限性肾癌在手术后出现复发转移。近年来，免疫治疗在转移性肾癌治疗中已取得重大进展，尤其是一些免疫治疗药物(如免疫检查点抑制剂、肿瘤疫苗等)已被证实能改善晚期肾癌患者的预后。该研究将综述免疫治疗在晚期转移性肾癌中的应用和研究进展。

Abstract

Renal cancer is one of the most common genitourinary carcers. However

25% patients present with locally invasive or metastatic renal cancer at the time of diagnosis

and one third of patients who received esection of localized disease will have a recurrence or progression. Recently

immunotherapy for renal cancer has made significant progress. Especially

some immunotherapeutic agents (such as immune checkpoint inhibitor

tumor vaccine) have been proved to improve the prognosis of patients with metastatic renal cancer. In this review

the effects of immunotherapeutic agents in the treatment of renal cancer were summarized.

关键词

Keywords

references

Views

3102

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

MDT consensus on immunotherapy for locally advanced head and neck squamous cell carcinoma (2025 edition)

Advances and future perspectives of neoadjuvant immunotherapy in colorectal cancer

Application progress of oncolytic virus combined with immunotherapy in the treatment of malignant tumors

Current status and future directions of immunotherapy for advanced non-small cell lung cancer

The immunotherapy for head and neck cancer

Related Author

Ye GUO

Chaosu HU

Chenping ZHANG

Yuyang ZHANG

Qian LIU

Yingyun LIANG

Jianhua CHEN

Chunxia SU

Related Institution

Committee of Head and Neck Cancer, Chinese Society of Clinical Oncology

Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University

AI问答

⁰